{"doc":{"info":{"calaisRequestID":"bc488b44-ffd0-0729-15e8-c3646ff458c0","id":"http:\/\/id.opencalais.com\/Bi2zXcgFQ85NihG-0OOJTQ","ontology":"http:\/\/mdaas-virtual-onecalais.int.thomsonreuters.com\/owlschema\/11.0\/onecalais.owl.allmetadata.xml","docId":"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d","document":"(EMAILWIRE.COM, September 16, 2017 ) Global In-Vitro diagnostics market has been estimated at USD 59.45 billion in 2016 and is expected to reach 78.07 billion at a Compound Annual Growth Rate (CAGR) of 5.6%. In-Vitro diagnostics can be described as tests that can help in detecting diseases, conditions or infections. Some of these tests are performed in laboratory or healthcare settings while other tests are for consumers to use at home.\n\nIVD Market test a sample of tissue or body fluids for microbial cultures or blood glucose. They are also used for testing changes in the liver function, imbalance in calcium levels in the body and electrolytes in the blood such as sodium, urea, potassium and Creatinine. The end users of In Vitro diagnostics market are generally Laboratories, Hospitals, Academic institutions, Point-of-care testing centers. There are around 40,000 IVD products available in the market assisting patients and specialists on a wide range of conditions\n\nBrowse market data tables and in-depth TOC of the Global In-Vitro Diagnostics Industry to 2021 @ http:\/\/www.marketdataforecast.com\/market-reports\/global-in-vitro-diagnostics-market-146\/\n\nGlobal In-Vitro Diagnostics market is expected to witness faster growth owing to advancements and innovations in the IVD technologies. Rising geriatric population base, growing prevalence of diabetes are the key factors driving the growth of the market. Increasing recognition of the diabetic's role in the patient care and rapidly evolving healthcare environment due to growing awareness about various diseases are expected to drive the In-Vitro market in the forecast period. However stringent regulatory policies and unclear reimbursement policies are restraining the growth of the market.\n\nFree sample of the report is available @ http:\/\/www.marketdataforecast.com\/market-reports\/global-in-vitro-diagnostics-market-146\/request-sample\n\nGlobal market for In-Vitro Diagnostics is segmented by product, by technology and by application. On the basis of product the market is again sub segmented into instruments, reagents and kits, Data management system\/software and services. On the basis of technology the in-vitro diagnostics market is sub segmented into Clinical Chemistry, Hematology, immunoassays, Coagulation and Hemostasis, molecular diagnostics, microbiology and other IVD technologies. On the basis of application the market for In-Vitro diagnostics is segmented into Diabetes, Infectious Diseases, Oncology\/Cancer, Cardiology, Nephrology, Autoimmune Diseases, Drug testing and HIV\n\nOn the basis of geography global market for In-Vitro diagnostics is segmented into North America, Asia-Pacific, Europe, Latin America and Middle-East & Africa. North America Is the largest market for In-Vitro diagnostics accounting for a share of around 37% owing to growing prevalence of chronic diseases such as cancer and respiratory diseases in the region while Asia-Pacific is estimated to be the fastest growing segment with a CAGR of 6.4%.\n\nInquire before Buying @ http:\/\/www.marketdataforecast.com\/market-reports\/global-in-vitro-diagnostics-market-146\/inquire\n\nAbbott Laboratories, Johnson and Johnson, Siemens Healthcare, Becton Dickinson, Roche Diagnostics, and Beckman Coulter Inc. are the major players dominating the global IVD market. Other companies which account for a significant share in the IVD market are Biomérieux, Ortho Clinical Diagnostics, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Sysmex Corporation and Thermo Fisher Scientific, Inc.\n\nAbout Us:\n\nMarket Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.\n\nVisit Market Data Forecast Blog @ http:\/\/www.marketdataforecast.com\/blog\/\n\nView latest Press Releases of MDF @ http:\/\/www.marketdataforecast.com\/press-releases","docTitle":"","docDate":"2017-09-16 19:42:01.511"},"meta":{"contentType":"text\/raw","processingVer":"AllMetadata","serverVersion":"OneCalais_11.0-RELEASE:169","stagsVer":"OneCalais_11.0-RELEASE-b10-2017-07-31_12:36:53","submissionDate":"2017-09-16 19:42:00.959","submitterCode":"0ca6a864-5659-789d-5f32-f365f695e757","signature":"digestalg-1|b72ScMxSiz\/tdp3guQwIF3QKCU0=|WNrjIjpOc537Bp5+yhtjftqm9lh+a9HEWoQSUAEqSV5b9L2O4UyrPg==","language":"English"}},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/cat\/1":{"_typeGroup":"topics","forenduserdisplay":"false","score":1,"name":"Business_Finance"},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/cat\/2":{"_typeGroup":"topics","forenduserdisplay":"false","score":1,"name":"Health_Medical_Pharma"},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/lid\/DefaultLangId":{"_typeGroup":"language","language":"http:\/\/d.opencalais.com\/lid\/DefaultLangId\/English","forenduserdisplay":"false","permid":"505062"},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/1":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/1","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/37d12d43-b641-3e05-bda8-0ffb0065cd21","forenduserdisplay":"true","name":"Medical tests","importance":"1","originalValue":"Medical tests"},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/2":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/2","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/5f34e2d5-9b90-3695-8854-40c95b0b235f","forenduserdisplay":"true","name":"Medicine","importance":"1","originalValue":"Medicine"},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/3":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/3","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/a4d237aa-c4e9-3f9b-a26f-70199de66284","forenduserdisplay":"true","name":"Biology","importance":"1","originalValue":"Biology"},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/4":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/4","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/623b01d7-2221-3867-ad97-cdf343a743f4","forenduserdisplay":"true","name":"Technology","importance":"2","originalValue":"Technology"},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/5":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/5","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/8194e754-ca7c-32b8-b4ad-3e0ddf3115b5","forenduserdisplay":"true","name":"Ortho Clinical Diagnostics","importance":"2","originalValue":"Ortho Clinical Diagnostics"},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/6":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/6","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/47b98384-6798-3689-8feb-0810989db618","forenduserdisplay":"true","name":"Bio-Rad Laboratories","importance":"2","originalValue":"Bio-Rad Laboratories"},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/7":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/7","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/ff4ed14c-5cbc-363f-a4fd-32f79f04e43a","forenduserdisplay":"true","name":"In vitro","importance":"2","originalValue":"In vitro"},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/8":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/8","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/a0e1c8a0-f4e0-3cf5-8b50-1d1cbbd1a55c","forenduserdisplay":"true","name":"Abbott Laboratories","importance":"2","originalValue":"Abbott Laboratories"},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/9":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/9","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/4eade424-787b-35b8-be5d-a847525bbd28","forenduserdisplay":"true","name":"Molecular diagnostics","importance":"2","originalValue":"Molecular diagnostics"},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/10":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/10","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/cb9054fb-ca34-396d-a30e-19e6f610df00","forenduserdisplay":"true","name":"IVD","importance":"2","originalValue":"IVD"},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/11":{"_typeGroup":"socialTag","id":"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/SocialTag\/11","socialTag":"http:\/\/d.opencalais.com\/genericHasher-1\/f8ea8f62-441d-366e-b769-1b84fce19a41","forenduserdisplay":"true","name":"Innogenetics","importance":"2","originalValue":"Innogenetics"},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/Industry\/1":{"_typeGroup":"industry","forenduserdisplay":"false","name":"Medical & Diagnostic Laboratories","rcscode":"B:1722","permid":"4294951279","relevance":0.2},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/Industry\/2":{"_typeGroup":"industry","forenduserdisplay":"false","name":"Biopharmaceuticals","rcscode":"B:1731","permid":"4294951270","relevance":0.8},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/Industry\/3":{"_typeGroup":"industry","forenduserdisplay":"false","name":"Medical Equipment, Supplies & Distribution - NEC","rcscode":"B:1707","permid":"4294951294","relevance":0.2},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/Industry\/4":{"_typeGroup":"industry","forenduserdisplay":"false","name":"Medical Supplies","rcscode":"B:1708","permid":"4294951293","relevance":0.2},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/Industry\/5":{"_typeGroup":"industry","forenduserdisplay":"false","name":"Hospitals, Clinics & Primary Care Services","rcscode":"B:1718","permid":"4294951283","relevance":0.2},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/Industry\/6":{"_typeGroup":"industry","forenduserdisplay":"false","name":"Biotechnology & Medical Research - NEC","rcscode":"B:1736","permid":"4294951265","relevance":0.2},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/Industry\/7":{"_typeGroup":"industry","forenduserdisplay":"false","name":"Pharmaceuticals - NEC","rcscode":"B:1729","permid":"4294951272","relevance":0.2},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/Industry\/8":{"_typeGroup":"industry","forenduserdisplay":"false","name":"Advanced Medical Equipment & Technology - NEC","rcscode":"B:1700","permid":"4294951301","relevance":0.2},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/Industry\/9":{"_typeGroup":"industry","forenduserdisplay":"false","name":"Diagnostic & Testing Substances","rcscode":"B:1714","permid":"4294951287","relevance":0.2},"http:\/\/d.opencalais.com\/dochash-1\/d5cee87f-c846-3462-8161-233d34c8854d\/ComponentVersions":{"_typeGroup":"versions","version":["DIY-Categorization-fnr-TRCS-capx:20170627191152:20170627191152","Deals Index:201709161840:201709161840","DIY-Categorization-fnr-TRCS-indx_stsale:20170323110805:20170323110805","DIY-Categorization-fnr-TRCS-comptn:20170621141739:20170621141739","index-refineries:201705201529:201705201529","DIY-Categorization-fnr-TRCS-regs_buyb_new:20170509091609:20170509091609","config-physicalAssets-powerStations:653:653","NextTags:OneCalais_11.0-RELEASE:169","DIY-Categorization-fnr-TRCS-dis:20170418132337:20170418132337","DIY-Categorization-fnr-TRCS-splitb_r1:20170329082516:20170329082516","config-sca-DataPackage:50:50","config-companyNe:655:655","DIY-Categorization-fnr-TRCS-acb:20170502102348:20170502102348","DIY-Categorization-fnr-TRCS-levrge:20170621122109:20170621122109","DIY-Categorization-fnr-TRCS-hedge_list1:20170315123823:20170315123823","config-refreshableDIY:1:1","People Index:201709161805:201709161805","DIY-Categorization-fnr-TRCS-awlq:20170331124441:20170331124441","config-negativeSignature:653:653","DIY-Categorization-fnr-TRCS-fake1_monop_bnkcap_new:20170405133257:20170405133257","Dial4J:OneCalais_8.6-RELEASE:209","DIY-Categorization-fnr-TRCS-dbtr_new:20170315123740:20170315123740","OA Override:672:672","DIY-Categorization-fnr-TRCS-hrgt:20170427081548:20170427081548","DIY-Categorization-fnr-TRCS-xpand:20170323144646:20170323144646","DIY-Categorization-fnr-TRCS-allcemrgdvst2:20170316142831:20170316142831","DIY-Categorization-fnr-TRCS-ordr:20170313151239:20170313151239","People Override:653:653","DIY-Categorization-fnr-TRCS-hrgt_recll:20170522120000:20170522120000","index-company-oa3:201709152235:201709152235","index-vessels:201709100045:201709100045","DIY-Categorization-fnr-TRCS-brib_r1:20170329090629:20170329090629","config-forEndUserDisplay:3:3","config-refineries:653:653","DIY-Categorization-fnr-TRCS-fapm:20170713144316:20170713144316","DIY-Categorization-fnr-TRCS-class:20170315123207:20170315123207","config-cse:672:672","DIY-Categorization-fnr-TRCS-isu_dat_r:20170315124144:20170315124144","DIY-Categorization-fnr-TRCS-cnsl_sisu:20170321144134:20170321144134","DIY-Categorization-fnr-TRCS-shract_r1:20170412111808:20170412111808","config-vessels:653:653","OneCalais:OneCalais_11.0-RELEASE:169","DIY-Categorization-fnr-TRCS-mktshr2:20170705120412:20170705120412","DIY-RCS-fnr-TRCS-cavs:4:4","DIY-Categorization-fnr-TRCS-trd_tax:20170309132522:20170309132522","DIY-Categorization-fnr-TRCS-sov_2:20170522130956:20170522130956","DIY-Categorization-fnr-TRCS-bons:20170406103713:20170406103713","DIY-Categorization-fnr-TRCS-hrgt_namec:20170329090731:20170329090731","DIY-RCS-fnr-TRCS-nd:3:3","DIY-Categorization-fnr-TRCS-stx:20170530123138:20170530123138","config-physicalAssets-mines:653:653","SocialTags Index:201709031835:201709031835","BlackList:672:672","index-ports:201709091840:201709091840","config-physicalAssets-ports:653:653","DIY-Categorization-fnr-TRCS-ream:20170529065740:20170529065740","DIY-Categorization-fnr-TRCS-chld:20170524084254:20170524084254","DIY-Categorization-fnr-TRCS-allce:20170323145654:20170323145654","DIY-Categorization-fnr-TRCS-medreg:20170508120210:20170508120210","config-drugs:653:653"]},"http:\/\/d.opencalais.com\/comphash-1\/9302ffd3-9a7d-32d9-9afe-fa7d64c787c8":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"SIEMENS HEALTHCARE","confidencelevel":"1.0","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[Laboratories, Johnson and Johnson, ]Siemens Healthcare[, Becton Dickinson, Roche Diagnostics, and]","prefix":"Laboratories, Johnson and Johnson, ","exact":"Siemens Healthcare","suffix":", Becton Dickinson, Roche Diagnostics, and","offset":3170,"length":18}],"relevance":0.2,"resolutions":[{"name":"Siemens Healthcare GmbH","permid":"5046274429","ispublic":"false","commonname":"Siemens Health","score":0.2618713,"id":"https:\/\/permid.org\/1-5046274429"}],"confidence":{"statisticalfeature":"0.668","dblookup":"0.0","resolution":"0.2618713","aggregate":"1.0"}},"http:\/\/d.opencalais.com\/genericHasher-1\/ae7bd5ec-9003-37ff-98df-282343699393":{"_typeGroup":"entities","_type":"URL","forenduserdisplay":"false","name":"http:\/\/www.marketdataforecast.com\/press-releases","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/URL","instances":[{"detection":"[latest Press Releases of MDF @ ]http:\/\/www.marketdataforecast.com\/press-releases[]","prefix":"latest Press Releases of MDF @ ","exact":"http:\/\/www.marketdataforecast.com\/press-releases","offset":4064,"length":48}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/df18b91e-c25b-391d-a552-c9ae71e627e0":{"_typeGroup":"entities","_type":"Region","forenduserdisplay":"false","name":"Latin America","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Region","instances":[{"detection":"[into North America, Asia-Pacific, Europe, ]Latin America[ and Middle-East & Africa. North America Is the]","prefix":"into North America, Asia-Pacific, Europe, ","exact":"Latin America","suffix":" and Middle-East & Africa. North America Is the","offset":2679,"length":13}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/6af607c7-e655-39a6-afbf-cfb4e9787ca4":{"_typeGroup":"entities","_type":"MedicalCondition","forenduserdisplay":"false","name":"Oncology\/Cancer","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/MedicalCondition","instances":[{"detection":"[ is segmented into Diabetes, Infectious Diseases, ]Oncology\/Cancer[, Cardiology, Nephrology, Autoimmune Diseases,]","prefix":" is segmented into Diabetes, Infectious Diseases, ","exact":"Oncology\/Cancer","suffix":", Cardiology, Nephrology, Autoimmune Diseases,","offset":2475,"length":15}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/148dd8a5-6faa-3d00-92a2-b2584e3d0868":{"_typeGroup":"entities","_type":"IndustryTerm","forenduserdisplay":"false","name":"healthcare environment","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/IndustryTerm","instances":[{"detection":"[role in the patient care and rapidly evolving ]healthcare environment[ due to growing awareness about various diseases]","prefix":"role in the patient care and rapidly evolving ","exact":"healthcare environment","suffix":" due to growing awareness about various diseases","offset":1506,"length":22}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/142c6072-e482-3db0-84ee-44bb9df61316":{"_typeGroup":"entities","_type":"MedicalCondition","forenduserdisplay":"false","name":"cancer","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/MedicalCondition","instances":[{"detection":"[growing prevalence of chronic diseases such as ]cancer[ and respiratory diseases in the region while]","prefix":"growing prevalence of chronic diseases such as ","exact":"cancer","suffix":" and respiratory diseases in the region while","offset":2873,"length":6}],"relevance":0.2},"http:\/\/d.opencalais.com\/comphash-1\/39a7cdf7-2529-373b-8de0-7b0afbe07047":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"Becton Dickinson","nationality":"N\/A","confidencelevel":"1.0","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[Johnson and Johnson, Siemens Healthcare, ]Becton Dickinson[, Roche Diagnostics, and Beckman Coulter Inc. are]","prefix":"Johnson and Johnson, Siemens Healthcare, ","exact":"Becton Dickinson","suffix":", Roche Diagnostics, and Beckman Coulter Inc. are","offset":3190,"length":16}],"relevance":0.2,"resolutions":[{"name":"BECTON, DICKINSON AND COMPANY","permid":"4295903533","primaryric":"BDX.N","ispublic":"true","commonname":"BD","score":0.95605713,"id":"https:\/\/permid.org\/1-4295903533","ticker":"BDX"}],"confidence":{"statisticalfeature":"0.914","dblookup":"0.0","resolution":"0.95605713","aggregate":"1.0"}},"http:\/\/d.opencalais.com\/genericHasher-1\/18248752-53b8-3d85-80d2-a51ecbdd759e":{"_typeGroup":"entities","_type":"MedicalCondition","forenduserdisplay":"false","name":"HIV","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/MedicalCondition","instances":[{"detection":"[Autoimmune Diseases, Drug testing and ]HIV[\n\nOn the basis of geography global market for]","prefix":"Autoimmune Diseases, Drug testing and ","exact":"HIV","suffix":"\n\nOn the basis of geography global market for","offset":2554,"length":3}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/6c128807-6d5d-3eef-a3b9-fd4a44bdeb32":{"_typeGroup":"entities","_type":"Technology","forenduserdisplay":"false","name":"IVD technologies","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Technology","instances":[{"detection":"[growth owing to advancements and innovations in ]the IVD technologies[. Rising geriatric population base, growing]","prefix":"growth owing to advancements and innovations in ","exact":"the IVD technologies","suffix":". Rising geriatric population base, growing","offset":1278,"length":20},{"detection":"[molecular diagnostics, microbiology and ]other IVD technologies[. On the basis of application the market for]","prefix":"molecular diagnostics, microbiology and ","exact":"other IVD technologies","suffix":". On the basis of application the market for","offset":2338,"length":22}],"relevance":0.2},"http:\/\/d.opencalais.com\/comphash-1\/d68a04cd-4a73-310e-8225-cd5771d55991":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"Sysmex Corporation","nationality":"N\/A","confidencelevel":"1.0","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[ Bio-Rad Laboratories, Inc., Danaher Corporation, ]Sysmex Corporation[ and Thermo Fisher Scientific, Inc.\n\nAbout]","prefix":" Bio-Rad Laboratories, Inc., Danaher Corporation, ","exact":"Sysmex Corporation","suffix":" and Thermo Fisher Scientific, Inc.\n\nAbout","offset":3479,"length":18}],"relevance":0.2,"resolutions":[{"name":"SYSMEX CORPORATION","permid":"4295877089","primaryric":"6869.T","ispublic":"true","commonname":"Sysmex","score":0.93384695,"id":"https:\/\/permid.org\/1-4295877089","ticker":"6869"}],"confidence":{"statisticalfeature":"0.823","dblookup":"0.0","resolution":"0.93384695","aggregate":"1.0"}},"http:\/\/d.opencalais.com\/genericHasher-1\/709b7a02-9fc6-3185-a285-f1a091de921b":{"_typeGroup":"entities","_type":"IndustryTerm","forenduserdisplay":"false","name":"management system\/software","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/IndustryTerm","instances":[{"detection":"[into instruments, reagents and kits, Data ]management system\/software[ and services. On the basis of technology the]","prefix":"into instruments, reagents and kits, Data ","exact":"management system\/software","suffix":" and services. On the basis of technology the","offset":2102,"length":26}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/37f0cf6b-b991-3dc8-8018-78338494cd3a":{"_typeGroup":"entities","_type":"Continent","forenduserdisplay":"false","name":"North America","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Continent","instances":[{"detection":"[for In-Vitro diagnostics is segmented into ]North America[, Asia-Pacific, Europe, Latin America and]","prefix":"for In-Vitro diagnostics is segmented into ","exact":"North America","suffix":", Asia-Pacific, Europe, Latin America and","offset":2642,"length":13},{"detection":"[Europe, Latin America and Middle-East & Africa. ]North America[ Is the largest market for In-Vitro diagnostics]","prefix":"Europe, Latin America and Middle-East & Africa. ","exact":"North America","suffix":" Is the largest market for In-Vitro diagnostics","offset":2719,"length":13}],"relevance":0.2},"http:\/\/d.opencalais.com\/comphash-1\/bdd2d67a-b837-34bc-9ffa-bb1afd0cb9a0":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"Johnson and Johnson","nationality":"N\/A","confidencelevel":"1.0","resolutions":[{"name":"JOHNSON & JOHNSON","permid":"4295904341","primaryric":"JNJ.N","ispublic":"true","commonname":"Johnson&Johnson","score":0.84350723,"id":"https:\/\/permid.org\/1-4295904341","ticker":"JNJ"}],"_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[gnostics-market-146\/inquire\n\nAbbott Laboratories, ]Johnson and Johnson[, Siemens Healthcare, Becton Dickinson, Roche]","prefix":"gnostics-market-146\/inquire\n\nAbbott Laboratories, ","exact":"Johnson and Johnson","suffix":", Siemens Healthcare, Becton Dickinson, Roche","offset":3149,"length":19}],"relevance":0.2,"confidence":{"statisticalfeature":"0.866","dblookup":"0.0","resolution":"0.84350723","aggregate":"1.0"}},"http:\/\/d.opencalais.com\/genericHasher-1\/44a28bea-3de5-323f-885d-98b2c78129a5":{"_typeGroup":"entities","_type":"MedicalCondition","forenduserdisplay":"false","name":"diabetes","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/MedicalCondition","instances":[{"detection":"[ geriatric population base, growing prevalence of ]diabetes[ are the key factors driving the growth of the]","prefix":" geriatric population base, growing prevalence of ","exact":"diabetes","suffix":" are the key factors driving the growth of the","offset":1356,"length":8},{"detection":"[for In-Vitro diagnostics is segmented into ]Diabetes[, Infectious Diseases, Oncology\/Cancer,]","prefix":"for In-Vitro diagnostics is segmented into ","exact":"Diabetes","suffix":", Infectious Diseases, Oncology\/Cancer,","offset":2444,"length":8}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/09bebb87-1ef5-373d-bd01-263e77470c65":{"_typeGroup":"entities","_type":"Continent","forenduserdisplay":"false","name":"Europe","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Continent","instances":[{"detection":"[is segmented into North America, Asia-Pacific, ]Europe[, Latin America and Middle-East & Africa. North]","prefix":"is segmented into North America, Asia-Pacific, ","exact":"Europe","suffix":", Latin America and Middle-East & Africa. North","offset":2671,"length":6}],"relevance":0.2},"http:\/\/d.opencalais.com\/comphash-1\/d082dde8-fefd-3f2d-a76d-fbbe376aa27a":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"Beckman Coulter Inc.","nationality":"N\/A","confidencelevel":"1.0","confidence":{"statisticalfeature":"0.999","dblookup":"0.0","resolution":"0.9937646","aggregate":"1.0"},"_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[Becton Dickinson, Roche Diagnostics, and ]Beckman Coulter Inc.[ are the major players dominating the global IVD]","prefix":"Becton Dickinson, Roche Diagnostics, and ","exact":"Beckman Coulter Inc.","suffix":" are the major players dominating the global IVD","offset":3231,"length":20}],"relevance":0.2,"resolutions":[{"name":"BECKMAN COULTER, INC.","permid":"4295903557","ispublic":"false","commonname":"Beckman Coulter","score":0.9937646,"id":"https:\/\/permid.org\/1-4295903557","ticker":"BEC"}]},"http:\/\/d.opencalais.com\/comphash-1\/54f4696e-b1ac-3f94-b359-611887baaa33":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"Roche Diagnostics","nationality":"N\/A","confidencelevel":"1.0","confidence":{"statisticalfeature":"0.929","dblookup":"0.0","resolution":"0.20751794","aggregate":"1.0"},"_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[Johnson, Siemens Healthcare, Becton Dickinson, ]Roche Diagnostics[, and Beckman Coulter Inc. are the major players]","prefix":"Johnson, Siemens Healthcare, Becton Dickinson, ","exact":"Roche Diagnostics","suffix":", and Beckman Coulter Inc. are the major players","offset":3208,"length":17}],"relevance":0.2,"resolutions":[{"name":"ROCHE DIAGNOSTICS CORPORATION","permid":"4296960945","ispublic":"false","commonname":"RDC","score":0.20751794,"id":"https:\/\/permid.org\/1-4296960945"}]},"http:\/\/d.opencalais.com\/comphash-1\/a1582e76-2c45-3e99-9a0c-554857833a18":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"false","name":"hematology","confidencelevel":"0.814","resolutions":[{"name":"Hematology Oncology P.C.","permid":"5037437540","ispublic":"false","commonname":"Hematology","score":0.015177098,"id":"https:\/\/permid.org\/1-5037437540"}],"confidence":{"statisticalfeature":"0.644","dblookup":"0.0","resolution":"0.015177098","aggregate":"0.814"},"_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[ market is sub segmented into Clinical Chemistry, ]Hematology[, immunoassays, Coagulation and Hemostasis,]","prefix":" market is sub segmented into Clinical Chemistry, ","exact":"Hematology","suffix":", immunoassays, Coagulation and Hemostasis,","offset":2244,"length":10}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/19cc1d3f-0865-39b0-b3d6-b3739cf3e66a":{"_typeGroup":"entities","_type":"Continent","forenduserdisplay":"false","name":"Africa","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Continent","instances":[{"detection":"[Europe, Latin America and Middle-East & ]Africa[. North America Is the largest market for]","prefix":"Europe, Latin America and Middle-East & ","exact":"Africa","suffix":". North America Is the largest market for","offset":2711,"length":6}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/8fdace30-1c27-3f74-a25b-b9a87cb97b30":{"_typeGroup":"entities","_type":"MedicalCondition","forenduserdisplay":"false","name":"diseases","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/MedicalCondition","instances":[{"detection":"[ be described as tests that can help in detecting ]diseases[, conditions or infections. Some of these tests]","prefix":" be described as tests that can help in detecting ","exact":"diseases","suffix":", conditions or infections. Some of these tests","offset":282,"length":8},{"detection":"[due to growing awareness about various ]diseases[ are expected to drive the In-Vitro market in the]","prefix":"due to growing awareness about various ","exact":"diseases","suffix":" are expected to drive the In-Vitro market in the","offset":1568,"length":8}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/a12b43d5-d195-35ea-96a9-f710943bdb5a":{"_typeGroup":"entities","_type":"Position","forenduserdisplay":"false","name":"analyst","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Position","instances":[{"detection":"[of both individual and corporate clients. Our ]analyst[ team comprises expert professionals in market]","prefix":"of both individual and corporate clients. Our ","exact":"analyst","suffix":" team comprises expert professionals in market","offset":3776,"length":7}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/cefe7f91-2845-33c7-bcd9-f6772a652d82":{"_typeGroup":"entities","_type":"IndustryTerm","forenduserdisplay":"false","name":"healthcare settings","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/IndustryTerm","instances":[{"detection":"[of these tests are performed in laboratory or ]healthcare settings[ while other tests are for consumers to use at]","prefix":"of these tests are performed in laboratory or ","exact":"healthcare settings","suffix":" while other tests are for consumers to use at","offset":369,"length":19}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/93c8efd3-e0a3-399f-9b77-e2d64814bcfd":{"_typeGroup":"entities","_type":"Region","forenduserdisplay":"false","name":"Asia-Pacific","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Region","instances":[{"detection":"[diagnostics is segmented into North America, ]Asia-Pacific[, Europe, Latin America and Middle-East & Africa.]","prefix":"diagnostics is segmented into North America, ","exact":"Asia-Pacific","suffix":", Europe, Latin America and Middle-East & Africa.","offset":2657,"length":12},{"detection":"[and respiratory diseases in the region while ]Asia-Pacific[ is estimated to be the fastest growing segment]","prefix":"and respiratory diseases in the region while ","exact":"Asia-Pacific","suffix":" is estimated to be the fastest growing segment","offset":2925,"length":12}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/052054a5-c86a-36bc-8eb5-046b822f660d":{"_typeGroup":"entities","_type":"MedicalCondition","forenduserdisplay":"false","name":"Infectious Diseases","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/MedicalCondition","instances":[{"detection":"[ In-Vitro diagnostics is segmented into Diabetes, ]Infectious Diseases[, Oncology\/Cancer, Cardiology, Nephrology,]","prefix":" In-Vitro diagnostics is segmented into Diabetes, ","exact":"Infectious Diseases","suffix":", Oncology\/Cancer, Cardiology, Nephrology,","offset":2454,"length":19}],"relevance":0.2},"http:\/\/d.opencalais.com\/comphash-1\/6f39c7ac-7ea4-325d-9364-1f7fc287b238":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"false","name":"Biomérieux","nationality":"N\/A","confidencelevel":"0.946","confidence":{"statisticalfeature":"0.889","dblookup":"0.0","resolution":"0.8709415","aggregate":"0.946"},"resolutions":[{"name":"BIOMERIEUX SA","permid":"5000073706","primaryric":"BIOX.PA","ispublic":"true","commonname":"bioMerieux","score":0.8709415,"id":"https:\/\/permid.org\/1-5000073706","ticker":"BIM"}],"_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[for a significant share in the IVD market are ]Biomérieux[, Ortho Clinical Diagnostics, Inc., Bio-Rad]","prefix":"for a significant share in the IVD market are ","exact":"Biomérieux","suffix":", Ortho Clinical Diagnostics, Inc., Bio-Rad","offset":3384,"length":10}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/47aeea07-e84b-3998-a532-06a8039f6770":{"_typeGroup":"entities","_type":"MedicalCondition","forenduserdisplay":"false","name":"chronic diseases","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/MedicalCondition","instances":[{"detection":"[of around 37% owing to growing prevalence of ]chronic diseases[ such as cancer and respiratory diseases in the]","prefix":"of around 37% owing to growing prevalence of ","exact":"chronic diseases","suffix":" such as cancer and respiratory diseases in the","offset":2848,"length":16}],"relevance":0.2},"http:\/\/d.opencalais.com\/comphash-1\/b6c2722a-bf67-3724-8954-b4cfe1656dec":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"Bio-Rad Laboratories Inc.","nationality":"N\/A","confidencelevel":"1.0","confidence":{"statisticalfeature":"0.908","dblookup":"0.0","resolution":"0.9937646","aggregate":"1.0"},"_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[Biomérieux, Ortho Clinical Diagnostics, Inc., ]Bio-Rad Laboratories, Inc.[, Danaher Corporation, Sysmex Corporation and]","prefix":"Biomérieux, Ortho Clinical Diagnostics, Inc., ","exact":"Bio-Rad Laboratories, Inc.","suffix":", Danaher Corporation, Sysmex Corporation and","offset":3430,"length":26}],"relevance":0.2,"resolutions":[{"name":"BIO-RAD LABORATORIES, INC.","permid":"4295908554","primaryric":"BIO.N","ispublic":"true","commonname":"Bio Rad","score":0.9937646,"id":"https:\/\/permid.org\/1-4295908554","ticker":"BIO"}]},"http:\/\/d.opencalais.com\/comphash-1\/9773f9d6-2b00-337a-949c-4bb6d6f57d19":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"Abbott Laboratories","nationality":"N\/A","confidencelevel":"1.0","resolutions":[{"name":"ABBOTT LABORATORIES","permid":"4295903265","primaryric":"ABT.N","ispublic":"true","commonname":"Abbott","score":0.987063,"id":"https:\/\/permid.org\/1-4295903265","ticker":"ABT"}],"confidence":{"statisticalfeature":"0.929","dblookup":"0.0","resolution":"0.987063","aggregate":"1.0"},"_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[s\/global-in-vitro-diagnostics-market-146\/inquire\n\n]Abbott Laboratories[, Johnson and Johnson, Siemens Healthcare, Becton]","prefix":"s\/global-in-vitro-diagnostics-market-146\/inquire\n\n","exact":"Abbott Laboratories","suffix":", Johnson and Johnson, Siemens Healthcare, Becton","offset":3128,"length":19}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/df4c05a8-ffbe-358f-82a7-ed3c51b5d264":{"_typeGroup":"entities","_type":"MedicalCondition","forenduserdisplay":"false","name":"infections","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/MedicalCondition","instances":[{"detection":"[can help in detecting diseases, conditions or ]infections[. Some of these tests are performed in laboratory]","prefix":"can help in detecting diseases, conditions or ","exact":"infections","suffix":". Some of these tests are performed in laboratory","offset":306,"length":10}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/cf6b8bb8-77c8-33d5-b212-e69bdccdf4e7":{"_typeGroup":"entities","_type":"Technology","forenduserdisplay":"false","name":"business intelligence","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Technology","instances":[{"detection":"[firm working in the area of market research and ]business intelligence[. With rich experience in research across various]","prefix":"firm working in the area of market research and ","exact":"business intelligence","suffix":". With rich experience in research across various","offset":3619,"length":21}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/5faf4210-4037-313e-87e0-e152e6deb5c0":{"_typeGroup":"entities","_type":"MedicalCondition","forenduserdisplay":"false","name":"respiratory diseases","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/MedicalCondition","instances":[{"detection":"[of chronic diseases such as cancer and ]respiratory diseases[ in the region while Asia-Pacific is estimated to]","prefix":"of chronic diseases such as cancer and ","exact":"respiratory diseases","suffix":" in the region while Asia-Pacific is estimated to","offset":2884,"length":20}],"relevance":0.2},"http:\/\/d.opencalais.com\/comphash-1\/90ad5920-abe0-3760-ba4f-ada2572b8601":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"Ortho Clinical Diagnostics Inc.","nationality":"N\/A","confidencelevel":"1.0","resolutions":[{"name":"ORTHO-CLINICAL DIAGNOSTICS, INC.","permid":"4296719316","ispublic":"false","commonname":"Ortho-Clinical","score":0.42573094,"id":"https:\/\/permid.org\/1-4296719316"}],"confidence":{"statisticalfeature":"0.842","dblookup":"0.0","resolution":"0.42573094","aggregate":"1.0"},"_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[share in the IVD market are Biomérieux, ]Ortho Clinical Diagnostics, Inc.[, Bio-Rad Laboratories, Inc., Danaher]","prefix":"share in the IVD market are Biomérieux, ","exact":"Ortho Clinical Diagnostics, Inc.","suffix":", Bio-Rad Laboratories, Inc., Danaher","offset":3396,"length":32}],"relevance":0.2},"http:\/\/d.opencalais.com\/comphash-1\/f9252975-1067-38c0-ac3f-366cf4c76a1a":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"Vitro Diagnostics","nationality":"N\/A","confidencelevel":"0.975","confidence":{"statisticalfeature":"0.97","dblookup":"0.0","resolution":"0.70157975","aggregate":"0.975"},"resolutions":[{"name":"VITRO DIAGNOSTICS, INC.","permid":"4295915377","primaryric":"VODG.PK","ispublic":"true","commonname":"Vitro Diag","score":0.70157975,"id":"https:\/\/permid.org\/1-4295915377","ticker":"VODG"}],"_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[September 16, 2017 ) Global In-]Vitro diagnostics[ market has been estimated at USD 59.45 billion]","prefix":"September 16, 2017 ) Global In-","exact":"Vitro diagnostics","suffix":" market has been estimated at USD 59.45 billion","offset":47,"length":17},{"detection":"[ a Compound Annual Growth Rate (CAGR) of 5.6%. In-]Vitro diagnostics[ can be described as tests that can help in]","prefix":" a Compound Annual Growth Rate (CAGR) of 5.6%. In-","exact":"Vitro diagnostics","suffix":" can be described as tests that can help in","offset":211,"length":17},{"detection":"[potassium and Creatinine. The end users of In ]Vitro diagnostics[ market are generally Laboratories, Hospitals,]","prefix":"potassium and Creatinine. The end users of In ","exact":"Vitro diagnostics","suffix":" market are generally Laboratories, Hospitals,","offset":733,"length":17},{"detection":"[data tables and in-depth TOC of the Global In-]Vitro Diagnostics[ Industry to 2021 @ http:\/\/www.marketdataforecast.]","prefix":"data tables and in-depth TOC of the Global In-","exact":"Vitro Diagnostics","suffix":" Industry to 2021 @ http:\/\/www.marketdataforecast.","offset":1038,"length":17},{"detection":"[lobal-in-vitro-diagnostics-market-146\/\n\nGlobal In-]Vitro Diagnostics[ market is expected to witness faster growth]","prefix":"lobal-in-vitro-diagnostics-market-146\/\n\nGlobal In-","exact":"Vitro Diagnostics","suffix":" market is expected to witness faster growth","offset":1175,"length":17},{"detection":"[s-market-146\/request-sample\n\nGlobal market for In-]Vitro Diagnostics[ is segmented by product, by technology and by]","prefix":"s-market-146\/request-sample\n\nGlobal market for In-","exact":"Vitro Diagnostics","suffix":" is segmented by product, by technology and by","offset":1925,"length":17},{"detection":"[On the basis of application the market for In-]Vitro diagnostics[ is segmented into Diabetes, Infectious Diseases,]","prefix":"On the basis of application the market for In-","exact":"Vitro diagnostics","suffix":" is segmented into Diabetes, Infectious Diseases,","offset":2408,"length":17},{"detection":"[the basis of geography global market for In-]Vitro diagnostics[ is segmented into North America, Asia-Pacific,]","prefix":"the basis of geography global market for In-","exact":"Vitro diagnostics","suffix":" is segmented into North America, Asia-Pacific,","offset":2606,"length":17},{"detection":"[North America Is the largest market for In-]Vitro diagnostics[ accounting for a share of around 37% owing to]","prefix":"North America Is the largest market for In-","exact":"Vitro diagnostics","suffix":" accounting for a share of around 37% owing to","offset":2762,"length":17}],"relevance":0.8},"http:\/\/d.opencalais.com\/genericHasher-1\/c1d78e51-2851-3daf-aef6-ee2262f456a2":{"_typeGroup":"entities","_type":"Technology","forenduserdisplay":"false","name":"In Vitro diagnostics","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Technology","instances":[{"detection":"[ urea, potassium and Creatinine. The end users of ]In Vitro diagnostics[ market are generally Laboratories, Hospitals,]","prefix":" urea, potassium and Creatinine. The end users of ","exact":"In Vitro diagnostics","suffix":" market are generally Laboratories, Hospitals,","offset":730,"length":20}],"relevance":0.2},"http:\/\/d.opencalais.com\/comphash-1\/cbc7ad99-9dcf-3f08-9bf7-89904a3451ce":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"Danaher Corporation","nationality":"N\/A","confidencelevel":"1.0","resolutions":[{"name":"DANAHER CORPORATION","permid":"4295903833","primaryric":"DHR.N","ispublic":"true","commonname":"Danaher","score":0.97307134,"id":"https:\/\/permid.org\/1-4295903833","ticker":"DHR"}],"confidence":{"statisticalfeature":"0.999","dblookup":"0.0","resolution":"0.97307134","aggregate":"1.0"},"_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[Diagnostics, Inc., Bio-Rad Laboratories, Inc., ]Danaher Corporation[, Sysmex Corporation and Thermo Fisher]","prefix":"Diagnostics, Inc., Bio-Rad Laboratories, Inc., ","exact":"Danaher Corporation","suffix":", Sysmex Corporation and Thermo Fisher","offset":3458,"length":19}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/c22051cc-940f-3b60-9aad-fd141441c4b5":{"_typeGroup":"entities","_type":"Region","forenduserdisplay":"false","name":"Middle-East","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Region","instances":[{"detection":"[ America, Asia-Pacific, Europe, Latin America and ]Middle-East[ & Africa. North America Is the largest market]","prefix":" America, Asia-Pacific, Europe, Latin America and ","exact":"Middle-East","suffix":" & Africa. North America Is the largest market","offset":2697,"length":11}],"relevance":0.2},"http:\/\/d.opencalais.com\/comphash-1\/800fb414-dbac-30db-8fea-65b26dbfaba4":{"_typeGroup":"entities","_type":"Company","forenduserdisplay":"true","name":"Thermo Fisher Scientific Inc.","nationality":"N\/A","confidencelevel":"1.0","confidence":{"statisticalfeature":"0.999","dblookup":"0.0","resolution":"0.9826517","aggregate":"1.0"},"resolutions":[{"name":"THERMO FISHER SCIENTIFIC INC.","permid":"4295905068","primaryric":"TMO.N","ispublic":"true","commonname":"Thermo Fisher","score":0.9826517,"id":"https:\/\/permid.org\/1-4295905068","ticker":"TMO"}],"_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/Company","instances":[{"detection":"[Danaher Corporation, Sysmex Corporation and ]Thermo Fisher Scientific, Inc.[\n\nAbout Us:\n\nMarket Data Forecast is a firm]","prefix":"Danaher Corporation, Sysmex Corporation and ","exact":"Thermo Fisher Scientific, Inc.","suffix":"\n\nAbout Us:\n\nMarket Data Forecast is a firm","offset":3502,"length":30}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/ce118d0c-56a3-3083-8cf8-9222497a316a":{"_typeGroup":"entities","_type":"MedicalCondition","forenduserdisplay":"false","name":"Autoimmune Diseases","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/e\/MedicalCondition","instances":[{"detection":"[Oncology\/Cancer, Cardiology, Nephrology, ]Autoimmune Diseases[, Drug testing and HIV\n\nOn the basis of geography]","prefix":"Oncology\/Cancer, Cardiology, Nephrology, ","exact":"Autoimmune Diseases","suffix":", Drug testing and HIV\n\nOn the basis of geography","offset":2516,"length":19}],"relevance":0.2},"http:\/\/d.opencalais.com\/genericHasher-1\/7b0ec104-7616-3e93-8493-a58363c23a09":{"_typeGroup":"relations","_type":"CompanyTechnology","forenduserdisplay":"false","_typeReference":"http:\/\/s.opencalais.com\/1\/type\/em\/r\/CompanyTechnology","company":"http:\/\/d.opencalais.com\/comphash-1\/f9252975-1067-38c0-ac3f-366cf4c76a1a","technology":"http:\/\/d.opencalais.com\/genericHasher-1\/6c128807-6d5d-3eef-a3b9-fd4a44bdeb32","instances":[{"detection":"[lobal-in-vitro-diagnostics-market-146\/\n\nGlobal In-]Vitro Diagnostics market is expected to witness faster growth owing to advancements and innovations in the IVD technologies[. Rising geriatric population base, growing]","prefix":"lobal-in-vitro-diagnostics-market-146\/\n\nGlobal In-","exact":"Vitro Diagnostics market is expected to witness faster growth owing to advancements and innovations in the IVD technologies","suffix":". Rising geriatric population base, growing","offset":1175,"length":123}]}}